Angelalign Technology Inc. Stock
Equities
6699
KYG0405D1051
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.25 HKD | -0.82% |
|
0.00% | +2.29% |
| Capitalization | 9.31B 10.29B 1.32B 1.12B 1.05B 985M 1.82B 120B 1.99B 12.28B 4.74B 56.49B 4.96B 4.86B 205B | P/E ratio 2025 * |
111x | P/E ratio 2026 * | 66.3x |
|---|---|---|---|---|---|
| Enterprise value | 7.69B 8.49B 1.09B 927M 867M 813M 1.5B 99.23B 1.64B 10.13B 3.91B 46.62B 4.09B 4.01B 169B | EV / Sales 2025 * |
3.19x | EV / Sales 2026 * | 2.63x |
| Free-Float |
29.42% | Yield 2025 * |
4.86% | Yield 2026 * | 2.65% |
| 1 day | -0.82% | ||
| Current month | -3.14% | ||
| 1 month | -10.67% | ||
| 3 months | -11.79% | ||
| 6 months | +4.51% | ||
| Current year | +2.29% |
| 1 week | 58.4 |  | 61.75 |
| 1 month | 58.4 | | 67.45 |
| Current year | 45.75 | | 77 |
| 1 year | 45.75 | | 77 |
| 3 years | 43.7 | | 139.8 |
| 5 years | 43.7 | | 490 |
| 10 years | 43.7 | | 490 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jiezhang Hu
CEO | Chief Executive Officer | 51 | 2023-07-30 |
Lily Li Dong
DFI | Director of Finance/CFO | 54 | 2023-04-02 |
Jie Tian
CTO | Chief Tech/Sci/R&D Officer | 59 | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dai Feng
CHM | Chairman | 49 | 2018-11-28 |
Kun Huang
BRD | Director/Board Member | 42 | 2018-11-28 |
Jiezhang Hu
BRD | Director/Board Member | 51 | 2020-12-20 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 33,076 M€ | +19.87% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.82% | 0.00% | +3.79% | -45.33% | 1.33B | |
| -0.77% | +3.92% | -19.92% | -11.15% | 19.19B | |
| +0.53% | +3.34% | -29.59% | -8.12% | 15.43B | |
| -1.39% | -3.76% | -10.46% | +25.52% | 11.5B | |
| -0.57% | +0.29% | - | - | 5.24B | |
| -3.57% | -10.99% | -8.73% | +2.37% | 2.26B | |
| +1.65% | +1.45% | -34.83% | -48.29% | 1.68B | |
| +0.18% | +2.84% | +31.72% | +120.24% | 652M | |
| -0.50% | +4.05% | -17.18% | +181.74% | 356M | |
| -4.60% | -2.20% | +36.70% | - | 337M | |
| Average | -1.07% | +0.55% | -5.39% | +27.12% | 5.8B | |
| Weighted average by Cap. | -0.43% | +1.74% | -19.06% | -0.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.41B 2.67B 343M 291M 272M 255M 471M 31.15B 516M 3.18B 1.23B 14.63B 1.29B 1.26B 53.05B | 2.92B 3.22B 414M 352M 329M 308M 569M 37.66B 624M 3.84B 1.48B 17.69B 1.55B 1.52B 64.12B |
| Net income | 85M 93.9M 12.07M 10.25M 9.59M 8.99M 16.59M 1.1B 18.18M 112M 43.22M 516M 45.27M 44.33M 1.87B | 143M 158M 20.26M 17.21M 16.1M 15.09M 27.85M 1.84B 30.53M 188M 72.56M 865M 76M 74.42M 3.14B |
| Net Debt | -1.63B -1.8B -231M -196M -184M -172M -318M -21.01B -348M -2.15B -828M -9.87B -867M -849M -35.78B | -1.63B -1.8B -232M -197M -184M -173M -319M -21.09B -350M -2.15B -831M -9.91B -870M -852M -35.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 60.25 $ | -0.82% | 379,653 |
| 25-12-15 | 60.75 $ | +0.33% | 457,588 |
| 25-12-12 | 60.55 $ | +2.89% | 240,860 |
| 25-12-11 | 58.85 $ | -1.75% | 321,080 |
| 25-12-10 | 59.90 $ | -0.08% | 143,657 |
Delayed Quote Hong Kong S.E., December 16, 2025 at 03:08 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6699 Stock
Select your edition
All financial news and data tailored to specific country editions
